
Developing a robust regulatory strategy early in the product development process is crucial for efficiently advancing a medical device through its lifecycle. Our regulatory strategies can encompass the entire development and marketing journey of the device or focus on specific aspects such as device modifications or changing regulatory requirements.
Starting with defining the product's classification as a medical device in the target geographic market, determining applicable regulations and standards, and outlining the necessary testing strategies, a well-defined regulatory strategy sets a solid foundation for the project and helps avoid surprises down the road.
ReguLogix Consulting offers classification determinations for devices in any geographic location. Whether reviewing classification rules in the EU, Canadian, or Australian medical device regulations or searching the US FDA device classification database, our determinations are backed by years of experience and provide clear justifications for the chosen classification.
Additionally to the above, we can assist you in selecting Notified and Approved Bodies. We can provide information on which bodies offer CE or UKCA marking and identify those with the available capacity to accept new clients.